Biotech

All Articles

Zephyrm finds Hong Kong IPO to fund period 3 cell treatment tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, submitting (PDF) for an...

Frazier Life Sciences gets $630M for small, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced a better $630 thousand for its fund concentrate...

GigaGen garners approximately $135M BARDA bucks to beat botulism

.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own technology...

GPCR firm Septerna files for IPO on stamina of preclinical data

.Septerna is about to learn exactly how a biotech without "any type of purposeful professional recor...

Kurma finalizes first $154M haul for most significant biotech fund as yet

.European VC organization Kurma Partners has introduced its own most current biotech fund, along wit...

Prothena promotes one officer while yet another leaves behind-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant leadership hirings, firings as we...

Editas capitalize Tip Cas9 licensing rights for $57M

.Versus the background of a Cas9 patent battle that rejects to pass away, Editas Medicine is actuall...

Ultragenyx adjusts gene treatment application to call up efficacy

.A minority of people taking Ultragenyx Drug's Wilson health condition genetics treatment UX701 have...

Biopharma unemployment rate supports in Q3: Intense Biotech evaluation

.As summer season warm relies on cool down winds, really hopes that this year will carry prevalent f...

J &amp J falls stage 2 dengue prospect in most current shift coming from vaccinations

.Johnson &amp Johnson's deprioritization of its contagious illness pipeline has asserted yet another...